GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » 3-Year EBITDA Growth Rate

Spectral Medical (TSX:EDT) 3-Year EBITDA Growth Rate : -9.60% (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical 3-Year EBITDA Growth Rate?

Spectral Medical's EBITDA per Share for the three months ended in Mar. 2024 was C$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was -9.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -27.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Spectral Medical was 47.70% per year. The lowest was -38.50% per year. And the median was 10.90% per year.


Competitive Comparison of Spectral Medical's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Spectral Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Spectral Medical's 3-Year EBITDA Growth Rate falls into.



Spectral Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Spectral Medical  (TSX:EDT) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Spectral Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Spectral Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical (TSX:EDT) Business Description

Traded in Other Exchanges
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.

Spectral Medical (TSX:EDT) Headlines